As part of a long-term plan to broaden its discovery capabilities in India, AMRI, a global contract research and manufacturing organisation, has hired two experts in medicinal and computational chemistry at its research centre in Hyderabad (HRC).
The company has also completed the relocation of custom library synthesis resources and capabilities to HRC from its Budapest, Hungary operations.
Srinivas Nanduri has been appointed as director of medicinal chemistry in India, reporting to Subramanyam Maddala, president of India Operations. In addition, Suneel Kumar Bommisetty, has been hired as senior research associate of computational chemistry, reporting to Nanduri.
In his most recent role as research director at Aurigene, Nanduri was responsible for the execution and overall supervision of multiple integrated drug discovery projects. Prior to that, he was chief scientific manager at Biocon-BMS Research Centre. Nanduri has also worked at Dr Reddy's.
Bommisetty joins AMRI from GVK Biosciences and brings more than eight years of computational chemistry experience to HRC. He began his career as a research associate in 2004. He played a dual role in GVK as a scientific associate and also as a senior faculty in GVK Bio campus, leading theory classes and lab sessions on molecular modelling, homology modelling, structure-based drug design and analogue-based drug design.
